Upgrade to SI Premium - Free Trial

Protara Therapeutics (TARA)

2.49 +0.01 (0.40%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/2/26)

Latest Headlines

Protara completes enrollment in THRIVE-3 Phase 2b trial October 15, 2026 8:00 AM - StreetInsider Protara Therapeutics Completes Enrollment of the Phase 2b Open-Label Dose Confirmation Phase of the THRIVE-3 Registrational Trial of IV Choline Chloride in Patients on Parenteral Support October 15, 2026 8:00 AM - Globe NewsWire Protara Therapeutics (TARA) Reiterated at Overweight by Cantor Fitzgerald After Management Meet October 15, 2026 7:54 AM - StreetInsider Form SCHEDULE 13G/A Protara Therapeutics, Filed by: Janus Henderson Group Ltd. August 13, 2026 12:47 PM - SEC Filing Form S-8 Protara Therapeutics, August 11, 2026 4:16 PM - SEC Filing Protara Therapeutics, Inc. (TARA) Misses Q2 EPS by 2c August 11, 2026 9:36 AM - StreetInsider Form 10-Q Protara Therapeutics, For: Jun 30 August 11, 2026 8:11 AM - SEC Filing Form 8-K Protara Therapeutics, For: Aug 11 August 11, 2026 8:06 AM - SEC Filing Protara Therapeutics Announces Second Quarter 2026 Financial Results and Provides a Business Update August 11, 2026 8:00 AM - Globe NewsWire Full Article List